Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2012

Open Access 01-12-2012 | Research

The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country

Authors: Prasad Katulanda, Priyanga Ranasinghe, Ranil Jayawardena, Godwin R Constantine, M H Rezvi Sheriff, David R Matthews

Published in: Diabetology & Metabolic Syndrome | Issue 1/2012

Login to get access

Abstract

Prevalence of diabetes mellitus (DM) has reached epidemic proportions in Sri Lanka. Presently there are studies on the community prevalence of distal peripheral neuropathy (DPN) in Sri Lanka. We describe prevalence, patterns and predictors of DPN in patients with DM in Sri Lanka. Data were collected as part of a national study on DM. In new cases DPN was assessed using the Diabetic-Neuropathy-Symptom (DNS) score, while in those with established diabetes both DNS and Toronto-Clinical-Scoring-System (TCSS) were used. A binary logistic-regression analysis was performed with ‘presence of DPN’ as the dichomatous dependent variable and other independent co-variants. The study included 528 diabetic patients (191-new cases), with a mean age of 55.0 ± 12.4 years and 37.3% were males, while 18% were from urban areas. Prevalence of DPN according to DNS score among all patients, patients with already established diabetes and newly diagnosed patients were 48.1%, 59.1% and 28.8% respectively. Prevalence of DPN in those with established DM as assessed by TCSS was 24% and the majority had mild DPN (16.6%). The remainder of the abstract is based on subjects with established DM. The prevalence of DPN in males and female was 20.0% and 26.4% respectively. The mean age of those with and without DPN was 62.1 ± 10.8 and 55.1 ± 10.8 years respectively (p < 0.001). The majority of those with DPN were from rural-areas (75.3%) and earned a monthly income < Sri Lankan Rupees 12,000 (87.6%). In the binary logistic-regression presence of foot ulcers (OR:10.4; 95%CI 1.8–16.7), female gender (OR:6.7; 95%CI 2.0–9.8) and smoking (OR:5.9; 95%CI 1.4–9.7) were the strongest predictors followed by insulin treatment (OR:4.3; 95%CI 1.3–6.9), diabetic retinopathy (OR:2.7; 95%CI 1.3–5.4), treatment with sulphonylureas (OR:1.8; 95%CI 1.1–3.2), increasing height (OR:1.8; 95%CI 1.2–2.4), rural residence (OR:1.8; 95%CI 1.1–2.5), higher levels of triglycerides (OR:1.6; 95%CI 1.2–2.0) and longer duration of DM (OR:1.2; 95%CI 1.1–1.3). There is a high prevalence of DPN among Sri Lankan adults with diabetes. The study defines the impact of previously known risk factors for development of DPN and identifies several new potential risk factors in an ethnically different large subpopulation with DM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
2.
go back to reference Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, et al: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002, 19 (5): 377-384. 10.1046/j.1464-5491.2002.00698.x.CrossRefPubMed Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, et al: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002, 19 (5): 377-384. 10.1046/j.1464-5491.2002.00698.x.CrossRefPubMed
3.
go back to reference Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ: Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004, 21 (9): 976-982. 10.1111/j.1464-5491.2004.01271.x.CrossRefPubMed Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ: Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004, 21 (9): 976-982. 10.1111/j.1464-5491.2004.01271.x.CrossRefPubMed
4.
go back to reference American Diabetes Association, American Academy of Neurology: Consensus statement: report and recommendations of the san antonio conference on diabetic neuropathy. american diabetes association american academy of neurology. Diabetes Care. 1988, 11 (7): 592-597.CrossRef American Diabetes Association, American Academy of Neurology: Consensus statement: report and recommendations of the san antonio conference on diabetic neuropathy. american diabetes association american academy of neurology. Diabetes Care. 1988, 11 (7): 592-597.CrossRef
5.
go back to reference Melton LJI, Dyck PJ: Epidemiology: In Diabetic Neuropathy. 1999, W.B. Saunders, Philadelphia, 2 edition Melton LJI, Dyck PJ: Epidemiology: In Diabetic Neuropathy. 1999, W.B. Saunders, Philadelphia, 2 edition
6.
go back to reference Jeffcoate WJ, Harding KG: Diabetic foot ulcers. Lancet. 2003, 361 (9368): 1545-1551. 10.1016/S0140-6736(03)13169-8.CrossRefPubMed Jeffcoate WJ, Harding KG: Diabetic foot ulcers. Lancet. 2003, 361 (9368): 1545-1551. 10.1016/S0140-6736(03)13169-8.CrossRefPubMed
7.
go back to reference Stevens MJ, Feldman EL, Greene DA: The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet Med. 1995, 12 (7): 566-579. 10.1111/j.1464-5491.1995.tb00544.x.CrossRefPubMed Stevens MJ, Feldman EL, Greene DA: The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet Med. 1995, 12 (7): 566-579. 10.1111/j.1464-5491.1995.tb00544.x.CrossRefPubMed
8.
go back to reference Schmader KE: Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002, 18 (6): 350-354. 10.1097/00002508-200211000-00002.CrossRefPubMed Schmader KE: Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002, 18 (6): 350-354. 10.1097/00002508-200211000-00002.CrossRefPubMed
9.
go back to reference Boulton AJ, Cavanagh PR, Rayman G: The foot in diabetes. 2006, John Wiley & Sons Ltd, Hoboken, 4 editionCrossRef Boulton AJ, Cavanagh PR, Rayman G: The foot in diabetes. 2006, John Wiley & Sons Ltd, Hoboken, 4 editionCrossRef
10.
go back to reference Morkrid K, Ali L, Hussain A: Risk factors and prevalence of diabetic peripheral neuropathy:a study of type 2 diabetic outpatients in Bangladesh. Int J Diabetes Dev Ctries. 2010, 30 (1): 11-17. 10.4103/0973-3930.60004.PubMedCentralCrossRefPubMed Morkrid K, Ali L, Hussain A: Risk factors and prevalence of diabetic peripheral neuropathy:a study of type 2 diabetic outpatients in Bangladesh. Int J Diabetes Dev Ctries. 2010, 30 (1): 11-17. 10.4103/0973-3930.60004.PubMedCentralCrossRefPubMed
11.
go back to reference Mather HM, Keen H: The Southall diabetes survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed). 1985, 291 (6502): 1081-1084. 10.1136/bmj.291.6502.1081.CrossRef Mather HM, Keen H: The Southall diabetes survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed). 1985, 291 (6502): 1081-1084. 10.1136/bmj.291.6502.1081.CrossRef
12.
go back to reference Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ: Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study. Diabetes Care. 2005, 28 (8): 1869-1875. 10.2337/diacare.28.8.1869.CrossRefPubMed Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ: Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study. Diabetes Care. 2005, 28 (8): 1869-1875. 10.2337/diacare.28.8.1869.CrossRefPubMed
13.
go back to reference Chaturvedi N, Abbott CA, Whalley A, Widdows P, Leggetter SY, Boulton AJ: Risk of diabetes-related amputation in South Asians vs. Europeans in the UK. Diabet Med. 2002, 19 (2): 99-104. 10.1046/j.1464-5491.2002.00583.x.CrossRefPubMed Chaturvedi N, Abbott CA, Whalley A, Widdows P, Leggetter SY, Boulton AJ: Risk of diabetes-related amputation in South Asians vs. Europeans in the UK. Diabet Med. 2002, 19 (2): 99-104. 10.1046/j.1464-5491.2002.00583.x.CrossRefPubMed
15.
go back to reference Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RD, Wijeratne S, Wijesuriya M, McCarthy MI, Adler AI, Matthews DR: Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka–Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet Med. 2008, 25 (9): 1062-1069. 10.1111/j.1464-5491.2008.02523.x.CrossRefPubMed Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RD, Wijeratne S, Wijesuriya M, McCarthy MI, Adler AI, Matthews DR: Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka–Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet Med. 2008, 25 (9): 1062-1069. 10.1111/j.1464-5491.2008.02523.x.CrossRefPubMed
16.
go back to reference American Diabetes Association: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997, 20 (7): 1183-1197.CrossRef American Diabetes Association: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997, 20 (7): 1183-1197.CrossRef
17.
go back to reference World Health Organization: Part 1. Diagnosis and Classification of Diabetes Mellitus. In Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. 1999, WHO, Geneva World Health Organization: Part 1. Diagnosis and Classification of Diabetes Mellitus. In Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. 1999, WHO, Geneva
18.
go back to reference WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004, 363 (9403): 157-163.CrossRef WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004, 363 (9403): 157-163.CrossRef
19.
go back to reference Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH: Diabetic nephropathy. Diabetol Metab Syndr. 2009, 1 (1): 10-10.1186/1758-5996-1-10.PubMedCentralCrossRefPubMed Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH: Diabetic nephropathy. Diabetol Metab Syndr. 2009, 1 (1): 10-10.1186/1758-5996-1-10.PubMedCentralCrossRefPubMed
20.
go back to reference Perkins BA, Olaleye D, Zinman B, Bril V: Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001, 24 (2): 250-256. 10.2337/diacare.24.2.250.CrossRefPubMed Perkins BA, Olaleye D, Zinman B, Bril V: Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001, 24 (2): 250-256. 10.2337/diacare.24.2.250.CrossRefPubMed
21.
go back to reference Meijer JW, Smit AJ, Sonderen EV, Groothoff JW, Eisma WH, Links TP: Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med. 2002, 19 (11): 962-965. 10.1046/j.1464-5491.2002.00819.x.CrossRefPubMed Meijer JW, Smit AJ, Sonderen EV, Groothoff JW, Eisma WH, Links TP: Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med. 2002, 19 (11): 962-965. 10.1046/j.1464-5491.2002.00819.x.CrossRefPubMed
23.
go back to reference Mayfield JA, Sugarman JR: The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot and amputation in persons with diabetes. J Fam Pract. 2000, 49 (Suppl 11): S17-S29.PubMed Mayfield JA, Sugarman JR: The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot and amputation in persons with diabetes. J Fam Pract. 2000, 49 (Suppl 11): S17-S29.PubMed
24.
go back to reference San Antonio Conference on Diabetic Neuropathy: Consensus statement: report and recommendations of the san antonio conference on diabetic neuropathy. american diabetes association american academy of neurology. Diabetes Care. 1988, 11 (7): 592-597.CrossRef San Antonio Conference on Diabetic Neuropathy: Consensus statement: report and recommendations of the san antonio conference on diabetic neuropathy. american diabetes association american academy of neurology. Diabetes Care. 1988, 11 (7): 592-597.CrossRef
25.
go back to reference Dutta A, Naorem S, Singh TP, Wangjam K: Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics mellitus. International Journal of Diabetes in Developing Countries. 2005, 25: 30-33. 10.4103/0973-3930.26756.CrossRef Dutta A, Naorem S, Singh TP, Wangjam K: Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics mellitus. International Journal of Diabetes in Developing Countries. 2005, 25: 30-33. 10.4103/0973-3930.26756.CrossRef
26.
go back to reference Khuwaja AK, Rafique G, White F, Azam SI: Macrovascular complications and their associated factors among persons with type 2 diabetes in Karachi, Pakistan - a multi - center study. J Pak Med Assoc. 2004, 54: 60-66.PubMed Khuwaja AK, Rafique G, White F, Azam SI: Macrovascular complications and their associated factors among persons with type 2 diabetes in Karachi, Pakistan - a multi - center study. J Pak Med Assoc. 2004, 54: 60-66.PubMed
27.
go back to reference Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993, 36 (2): 150-154. 10.1007/BF00400697.CrossRefPubMed Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993, 36 (2): 150-154. 10.1007/BF00400697.CrossRefPubMed
28.
go back to reference Liu F, Bao Y, Hu R, Zhang X, Li H, Zhu D, Li Y, Yan L, Lu J, Li Q, et al: Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of China. Diabetes Metab Res Rev. 2010, 26 (6): 481-489. 10.1002/dmrr.1107.CrossRefPubMed Liu F, Bao Y, Hu R, Zhang X, Li H, Zhu D, Li Y, Yan L, Lu J, Li Q, et al: Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of China. Diabetes Metab Res Rev. 2010, 26 (6): 481-489. 10.1002/dmrr.1107.CrossRefPubMed
29.
go back to reference Rahimdel A, Afkhami-Ardekani M, Souzani A, Modaresi M, Mashahiri MR: Prevalence of Sensory Neuropathy in Type 2 Diabetic Patients in Iranian Population (Yazd Province). Iranian Journal of Diabetes and Obesity. 2009, 1 (1): 30-35. Rahimdel A, Afkhami-Ardekani M, Souzani A, Modaresi M, Mashahiri MR: Prevalence of Sensory Neuropathy in Type 2 Diabetic Patients in Iranian Population (Yazd Province). Iranian Journal of Diabetes and Obesity. 2009, 1 (1): 30-35.
30.
go back to reference Gill G, Gebrekidan A, English P, Wile D, Tesfaye S: Diabetic complications and glycaemic control in remote North Africa. QJM. 2008, 101 (10): 793-798. 10.1093/qjmed/hcn096.CrossRefPubMed Gill G, Gebrekidan A, English P, Wile D, Tesfaye S: Diabetic complications and glycaemic control in remote North Africa. QJM. 2008, 101 (10): 793-798. 10.1093/qjmed/hcn096.CrossRefPubMed
31.
go back to reference Savage S, Estacio RO, Jeffers B, Schrier RW: Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Proc Assoc Am Physicians. 1997, 109 (2): 181-189.PubMed Savage S, Estacio RO, Jeffers B, Schrier RW: Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Proc Assoc Am Physicians. 1997, 109 (2): 181-189.PubMed
32.
go back to reference Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998, 41 (4): 416-423. 10.1007/s001250050924.CrossRef Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998, 41 (4): 416-423. 10.1007/s001250050924.CrossRef
33.
go back to reference Detaille D, Guigas B, Chauvin C: Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes. 2005, 54: 2179-2187. 10.2337/diabetes.54.7.2179.CrossRefPubMed Detaille D, Guigas B, Chauvin C: Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes. 2005, 54: 2179-2187. 10.2337/diabetes.54.7.2179.CrossRefPubMed
34.
go back to reference Kou J, Klorig DC, Bloomquist JR: Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo. Neurotoxicology. 2006, 27 (5): 826-834. 10.1016/j.neuro.2006.04.004.CrossRefPubMed Kou J, Klorig DC, Bloomquist JR: Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo. Neurotoxicology. 2006, 27 (5): 826-834. 10.1016/j.neuro.2006.04.004.CrossRefPubMed
35.
go back to reference Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL: Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009, 58 (7): 1634-1640. 10.2337/db08-1771.PubMedCentralCrossRefPubMed Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL: Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009, 58 (7): 1634-1640. 10.2337/db08-1771.PubMedCentralCrossRefPubMed
36.
go back to reference Tesfaye S, Harris N, Jakubowski JJ, Mody C, Wilson RM, Rennie IG, Ward JD: Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia. 1993, 36 (12): 1266-1274. 10.1007/BF00400804.CrossRefPubMed Tesfaye S, Harris N, Jakubowski JJ, Mody C, Wilson RM, Rennie IG, Ward JD: Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia. 1993, 36 (12): 1266-1274. 10.1007/BF00400804.CrossRefPubMed
37.
go back to reference Thomas Pk, Ward Jd, Watkins Pj: Diabetic neuropathy. 1982, Edward Arnold, London, 109-136. Thomas Pk, Ward Jd, Watkins Pj: Diabetic neuropathy. 1982, Edward Arnold, London, 109-136.
38.
go back to reference Ibrahim S, Harris ND, Radatz M, Selmi F, Rajbhandari S, Brady L, Jakubowski J, Ward JD: A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy. Diabetologia. 1999, 42 (6): 737-742. 10.1007/s001250051222.CrossRefPubMed Ibrahim S, Harris ND, Radatz M, Selmi F, Rajbhandari S, Brady L, Jakubowski J, Ward JD: A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy. Diabetologia. 1999, 42 (6): 737-742. 10.1007/s001250051222.CrossRefPubMed
39.
go back to reference Karim F, Tripura A, Gani MS, Chowdhury AM: Poverty status and health equity: evidence from rural Bangladesh. Public Health. 2006, 120 (3): 193-205. 10.1016/j.puhe.2005.08.016.CrossRefPubMed Karim F, Tripura A, Gani MS, Chowdhury AM: Poverty status and health equity: evidence from rural Bangladesh. Public Health. 2006, 120 (3): 193-205. 10.1016/j.puhe.2005.08.016.CrossRefPubMed
40.
go back to reference Weng C, Coppini DV, Sonksen PH: Geographic and social factors are related to increased morbidity and mortality rates in diabetic patients. Diabet Med. 2000, 17 (8): 612-617. 10.1046/j.1464-5491.2000.00352.x.CrossRefPubMed Weng C, Coppini DV, Sonksen PH: Geographic and social factors are related to increased morbidity and mortality rates in diabetic patients. Diabet Med. 2000, 17 (8): 612-617. 10.1046/j.1464-5491.2000.00352.x.CrossRefPubMed
41.
go back to reference Polydefkis M, Hauer P, Sheth S: The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain. 2004, 127: 1606-1615. 10.1093/brain/awh175.CrossRefPubMed Polydefkis M, Hauer P, Sheth S: The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain. 2004, 127: 1606-1615. 10.1093/brain/awh175.CrossRefPubMed
42.
go back to reference The DCCT Research Group: Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes. 1988, 37 (4): 476-481.CrossRef The DCCT Research Group: Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes. 1988, 37 (4): 476-481.CrossRef
43.
go back to reference Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD: Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996, 39 (11): 1377-1384. 10.1007/s001250050586.CrossRefPubMed Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD: Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996, 39 (11): 1377-1384. 10.1007/s001250050586.CrossRefPubMed
Metadata
Title
The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country
Authors
Prasad Katulanda
Priyanga Ranasinghe
Ranil Jayawardena
Godwin R Constantine
M H Rezvi Sheriff
David R Matthews
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2012
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-4-21

Other articles of this Issue 1/2012

Diabetology & Metabolic Syndrome 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.